The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs

• Main Authors: Simona Federica Spampinato, Grazia Ilaria Caruso, Rocco De Pasquale, Maria Angela Sortino, Sara Merlo
• Format: Article
• Language: English
• Published: MDPI AG 2020-04-01
• Series: Pharmaceuticals
• Subjects: wound closure; diabetic foot ulcer; DPP4 inhibitor; metformin; phenytoin; statins
• Online Access: https://www.mdpi.com/1424-8247/13/4/60

Chronic wounds often occur in patients with diabetes mellitus due to the impairment of wound healing. This has negative consequences for both the patient and the medical system and considering the growing prevalence of diabetes, it will be a significant medical, social, and economic burden in the near future. Hence, the need for therapeutic alternatives to the current available treatments that, although various, do not guarantee a rapid and definite reparative process, appears necessary. We here analyzed current treatments for wound healing, but mainly focused the attention on few classes of drugs that are already in the market with different indications, but that have shown in preclinical and few clinical trials the potentiality to be used in the treatment of impaired wound healing. In particular, repurposing of the antiglycemic agents dipeptidylpeptidase 4 (DPP4) inhibitors and metformin, but also, statins and phenyotin have been analyzed. All show encouraging results in the treatment of chronic wounds, but additional, well designed studies are needed to allow these drugs access to the clinics in the therapy of impaired wound healing.